Literature DB >> 502760

Chronic desipramine treatment increases activity of noradrenergic postsynaptic cells.

Y H Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 502760     DOI： 10.1016/0024-3205(79)90513-7

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  5 in total

1.  A monoclonal antibody (HO-No-1) with specificity for a human nucleolar protein.

Authors:  Y S Ho; C Z Huang; Y C Tu
Journal:  Br J Exp Pathol       Date:  1987-12

2.  Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus in vivo.

Authors:  J J O'Connor; M J Rowan; R Anwyl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

3.  Behavioural changes during withdrawal from desmethylimipramine (DMI). II. Increased resistance to extinction.

Authors:  P Willner; T Montgomery; D Bird
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine.

Authors:  P Willner; T Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  The effect of peripheral noradrenaline depletion on responding on a schedule of differential reinforcement of low rates of response (DRL).

Authors:  P Salmon; C Stanford; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.